This research develops water-free electrolyte systems for electrochemical reactions and energy technologies. By replacing water with more stable solvents, the work enables improved batteries, renewable energy storage, and more efficient chemical manufacturing. Applications include long-range electric vehicles, planetary exploration systems, and lower-cost pharmaceutical production using recyclable chemical reagents.

This research develops a new chemical process for modifying cellulose while keeping it in water, overcoming longstanding compatibility problems between cellulose and oil-soluble molecules. The method enables cellulose to incorporate electronic and pharmaceutical components, opening pathways toward sustainable electronics, advanced materials, targeted medicines, and greener technologies based on renewable natural resources.

This research develops “nanozymes,” nanoparticle-based catalysts that activate cancer drugs directly at tumor sites. Instead of carrying large amounts of chemotherapy drugs, nanozymes locally trigger inactive drugs into their active form only within cancer tissue. Early mouse studies show effective tumor destruction with significantly reduced side effects compared to conventional chemotherapy.

This research develops methods to insert radioactive carbon isotopes into drug molecules, allowing scientists to track how medicines move, transform, and are eliminated in the body. By using catalysts to precisely label drugs, researchers can better understand drug behaviour and accelerate the development of safer, more effective medicines.

This research addresses antibiotic resistance by developing new compounds effective against Pseudomonas aeruginosa. Using engineered Streptomyces albus, it produces uridyl peptide antibiotics with a triple-target mechanism that reduces resistance risk. The work focuses on purification and chemical optimization to create more effective, clinically viable antibiotics for future infections.